Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Farabaugh CS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brawley A; Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA, United States., Moffitt C; Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA, United States., Bruce SF; Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA, United States., Farabaugh CS; Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA, United States., Podczaski E; Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA, United States., Sorosky J; Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA, United States.
Publikováno v:
Gynecologic oncology reports [Gynecol Oncol Rep] 2024 Oct 13; Vol. 56, pp. 101530. Date of Electronic Publication: 2024 Oct 13 (Print Publication: 2024).
Autor:
Farabaugh CS; Charles River Laboratories, Skokie, IL, United States., Doak S; Institute of Life Science 2, Swansea University Medical School, Singleton Park, Swansea, Wales, United Kingdom., Roy S; Inotiv, Rockville, MD, United States., Elespuru R; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Columbia, MD, United States.
Publikováno v:
Frontiers in toxicology [Front Toxicol] 2023 Apr 26; Vol. 5, pp. 1171960. Date of Electronic Publication: 2023 Apr 26 (Print Publication: 2023).
Autor:
Haas AR; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tanyi JL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., O'Hara MH; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gladney WL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Lacey SF; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Torigian DA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Soulen MC; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tian L; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., McGarvey M; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Nelson AM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Farabaugh CS; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Moon E; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Levine BL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Melenhorst JJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Plesa G; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., June CH; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Albelda SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Beatty GL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: gregory.beatty@pennmedicine.upenn.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2019 Nov 06; Vol. 27 (11), pp. 1919-1929. Date of Electronic Publication: 2019 Jul 30.
Autor:
Kirkland D; Kirkland Consulting, PO Box 79, Tadcaster LS24 0AS, UK., Levy DD; US Food and Drug Administration Center for Food Safety and Applied Nutrition, College Park, MD, USA., LeBaron MJ; The Dow Chemical Company, Toxicology & Environmental Research & Consulting, Midland, MI, USA., Aardema MJ; Marilyn Aardema Consulting LLC, 5315 Oakbrook Dr., Fairfield, OH 45014, USA., Beevers C; Exponent International Ltd, Harrogate, UK., Bhalli J; MilliporeSigma, BioReliance Toxicology Testing Services, Rockville, MD, USA., Douglas GR; Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A 0K9, Canada., Escobar PA; Merck & Co. Inc., West Point, PA 19486, USA., Farabaugh CS; Charles River Laboratories, Skokie, IL, USA., Guerard M; Roche Innovation Center Basel, pRed, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Johnson GE; Swansea University Medical School, Swansea, UK., Kulkarni R; MilliporeSigma, BioReliance Toxicology Testing Services, Rockville, MD, USA., Le Curieux F; European Chemicals Agency, Helsinki, Finland., Long AS; Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A 0K9, Canada., Lott J; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany., Lovell DP; St George's Medical School, University of London, London, UK., Luijten M; Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Marchetti F; Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A 0K9, Canada., Nicolette JJ; AbbVie, Inc., Pre-clinical Safety, North Chicago, Illinois, USA., Pfuhler S; Procter & Gamble, Global Product Stewardship, Mason, OH 45040, USA., Roberts DJ; Charles River Laboratories, Skokie, IL, USA., Stankowski LF Jr; Charles River Laboratories, Skokie, IL, USA., Thybaud V; Sanofi, Vitry-sur-Seine, France., Weiner SK; Janssen Research & Development, Spring House, PA 19477, USA., Williams A; Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A 0K9, Canada., Witt KL; National Institute of Environmental Health Sciences/Division of the National Toxicology Program, Research Triangle Park, NC, USA., Young R; MilliporeSigma, BioReliance Toxicology Testing Services, Rockville, MD, USA.
Publikováno v:
Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2019 Mar; Vol. 839, pp. 21-35. Date of Electronic Publication: 2019 Jan 18.
Autor:
Lovell DP; St George's Medical School, University of London, London, SW17 0RE, UK. Electronic address: dlovell@sgul.ac.uk., Fellow M; Astra Zeneca, Drug Safety and Metabolism, Cambridge, CB4 0WG, UK., Elhajouji A; Novartis Institutes for Biomedical Research, Preclinical Safety, Genetic Toxicology and photosafety, Basel, Switzerland., Farabaugh CS; Charles River Laboratories, Skokie, IN, USA., Gilby BG; Envigo CRS Limited, Cambs, UK., Hashimoto K; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan., Li Y; Covance Greenfield, Indianapolis, IN, USA., Roy S; Bioreliance, Rockville, MD, USA., Schuler M; Pfizer, Groton, CT, USA., Whitwell J; Covance Laboratories, Harrogate, North Yorkshire, HG3 1PY, UK., Tanir JY; ILSI Health and Environmental Sciences Institute (HESI), 1156 15th Street NW, 2nd Floor, Washington, DC 20005, USA.
Publikováno v:
Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2019 Jan; Vol. 837, pp. 52-59. Date of Electronic Publication: 2018 Sep 18.
Autor:
Elespuru R; Division of Biology, Chemistry and Materials Science, US Food and Drug Administration, CDRH/OSEL, Silver Spring, Maryland 20993., Pfuhler S; The Procter & Gamble Company, Mason Business Centre, Mason, Ohio 45040., Aardema MJ; Marilyn Aardema Consulting LLC, Fairfield, Ohio 45014., Chen T; Division of Genetic and Molecular Toxicology, US Food and Drug Administration, NCTR, Jefferson, Arkansas 72079., Doak SH; Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, UK., Doherty A; Discovery Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca Genetic Toxicology, AstraZeneca, Cambridge CB4 0WG, UK., Farabaugh CS; Charles River Laboratories Skokie, LLC, Skokie, Illinois 60077., Kenny J; Genetic Toxicology & Photosafety, David Jack Centre for Research & Development, GlaxoSmithKline, Ware, Hertfordshire SG12 0DP, UK., Manjanatha M; Division of Genetic and Molecular Toxicology, US Food and Drug Administration, NCTR, Jefferson, Arkansas 72079., Mahadevan B; Global Pre-clinical Development Innovation & Development, Established Pharmaceuticals, Abbott, Mumbai 400072, India., Moore MM; Ramboll Environ, Little Rock, Arkansas 72201., Ouédraogo G; L'Oreal, Research & Innovation, Aulnay sous Bois, France., Stankowski LF Jr; Charles River Laboratories Skokie, LLC, Skokie, Illinois 60077., Tanir JY; ILSI Health and Environmental Sciences Institute (HESI), Washington, District of Columbia 20005.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 Aug 01; Vol. 164 (2), pp. 391-416.